Vitex agnus castus extract in the treatment of luteal phase defects due to latent hyperprolactinemia. Results of a randomized placebo-controlled double-blind study
Milewicz A, Gejdel E, Sworen H, Sienkiewicz K, Jedrzejuk D, Teucher T
Published in Arzneimittelforschung, Vol. 43 (7), pp. 752-6
Methodology
Randomized double-blind placebo-controlled trial of Vitex agnus-castus extract in women with luteal phase defects due to latent hyperprolactinaemia.
Key Findings
Vitex reduced prolactin release, normalised shortened luteal phases and raised mid-luteal progesterone levels versus placebo.
Conclusions
Chasteberry can support luteal progesterone via prolactin reduction.
Limitations
Small, dated trial; narrow indication.
Supplements Studied
Vitex reduced prolactin release and raised mid-luteal progesterone levels versus placebo
Outcomes Measured
Vitex reduced prolactin release, normalised shortened luteal phases and raised mid-luteal progesterone levels versus placebo
Vitex reduced prolactin release, normalised shortened luteal phases and raised mid-luteal progesterone levels versus placebo
Vitex reduced prolactin release, normalised shortened luteal phases and raised mid-luteal progesterone levels versus placebo
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.